Start by asking whether an MDT discussion is actually available
The phrase multidisciplinary team, or MDT, describes a meeting where clinicians from more than one specialty review the same case together and produce a shared recommendation. It is not a single appointment and it is not a second opinion by one doctor. For bladder cancer, the relevant specialties typically include urology or urologic surgery, medical oncology, radiation oncology and pathology or radiology input. Which specialties attend, how often the meeting is held, and whether an overseas patient's records can be included are hospital-specific arrangements.
This matters because the value of an MDT comes from the exchange between specialties, not from the label. If a hospital tells you it offers multidisciplinary review, ask what that means in practice: who reviews the file, whether a pathologist re-reads the slides, whether the discussion happens before or after you travel, and how the conclusion is communicated to you in writing.
A records-based review arranged before travel is not the same as hospital acceptance, and it does not establish that a particular operation will be offered. Treat any preliminary opinion as a planning input, not a final decision. The treating hospital decides suitability after it has seen what it needs.
If you are comparing hospitals, ask each one the same question in the same words so the answers can be compared. A vague yes is less useful than a clear description of who attends and what the output looks like.
What the pathology and staging review must settle
The first substantive question an MDT should answer is whether the diagnosis and stage are clear enough to plan treatment. Bladder cancer is not one disease. The type of cancer, how deeply it has grown into the bladder wall, and whether there is evidence of spread beyond the bladder all change what is reasonable to offer. Those facts come from pathology reports on tissue samples and from imaging.
Ask specifically: has the original pathology been reviewed by the hospital's own pathologist, or is the plan based only on the report you brought? A re-read can confirm the diagnosis, clarify the tumour type and comment on features that affect treatment choices. If slides or blocks are not available, ask what the hospital can work with and what it would need.
Staging is the second half of this question. Ask which imaging has been done, whether it is recent enough to rely on, and whether the MDT believes anything further is needed before a plan can be recommended. Do not assume a scan done elsewhere will be accepted without review, and do not assume it will be repeated. Ask.
A useful output from this part of the discussion is a plain statement of what is known, what is uncertain, and what would change the recommendation. If the staging is genuinely borderline, that uncertainty should be stated rather than smoothed over.
Which previous bladder treatments have already been given
Bladder cancer can be treated with different approaches, and what has already been done strongly shapes what comes next. The MDT needs a clear treatment history, not just a diagnosis. That includes any surgery on the bladder, any instillation treatments delivered into the bladder, any systemic therapy, and any radiation to the pelvis.
Ask the hospital to confirm it has the actual treatment records, not a summary letter. Dates, agents used, number of cycles or instillations, and the response to each treatment all matter. If a treatment was stopped early, the reason is part of the history. If you do not have those records, ask what the hospital needs and how to obtain it.
This is also where you should ask whether the previous treatment changes the options now under discussion. A plan that ignores prior therapy is not a plan. If the MDT cannot reconstruct the treatment history from the records available, that gap should be named explicitly so you can fill it.
Keep your own dated list of treatments and bring it to every conversation. It is a practical tool, not a substitute for the official records.
Urinary diversion and reconstruction need a separate, individual discussion
If removal of the bladder is being considered, the arrangement for passing urine afterwards requires its own surgical discussion. This is not a detail to be settled on the day of surgery. The options differ in how they work, what they require of you, and what follow-up they need, and the right choice depends on the disease, your anatomy, your general health and your own priorities.
Ask the MDT to explain which reconstructive options are realistically available in your case and why. Ask who would perform that part of the operation and what experience the team has with each option. Ask what the alternatives are if the preferred approach turns out not to be suitable during surgery.
Ask about the practical consequences you will live with: how urine is stored and emptied, what devices or supplies are involved, what training you would need, and what follow-up is required. Ask what can and cannot be guaranteed. Continence, sexual function and fertility outcomes vary between individuals and between procedures, and no clinician can promise a specific result.
This is also the point to ask about timing. If reconstruction is planned, is it done in the same operation or as a separate stage? What determines that? The answer is a clinical judgement, and it should be explained to you rather than assumed.
Questions the MDT should answer in writing before you commit
A verbal summary in a corridor is not enough to plan an international trip. Ask for the discussion outcome in writing, in a form you can read and share with your own doctors at home. The document does not need to be long, but it should be specific.
Ask for a clear statement of the recommended plan and the reasoning behind it. Ask what alternatives were considered and why they were set aside. Ask what the team still needs before it can confirm the plan, and what could change it. Ask who will be responsible for each part of the treatment and who your point of contact will be.
Ask about the practical scope of any estimate you receive. A written quote should state what it includes, what it excludes and what remains undecided. If a component is not yet priced, ask for that to be identified rather than absorbed into a total. Ask the named hospital how its own estimate is structured, because billing arrangements are provider-specific.
Finally, ask what happens if the plan changes after you arrive. Overseas patients need to understand the decision points in advance, not discover them mid-treatment.
How to prepare your records and take the next step
Preparation is mostly about records. Gather your pathology report and, where possible, the slides or blocks. Gather imaging reports and the images themselves if they can be shared. Gather a dated treatment history with agents, cycles and responses. Gather a current medication list and a short summary of other significant health conditions.
Then write down your own questions before any discussion. The four that matter most are: what does the pathology and staging show, what treatments have already been given, what surgical and reconstructive options are realistic, and what still needs to be confirmed. Add anything personal to you, such as work, travel or family constraints, because those affect timing decisions.
If you want to explore care in China, an initial enquiry is free and does not require buying a proxy consultation. A brief summary of the diagnosis, the records you hold and your main question is enough to start. The team can then indicate what is missing and which next step is relevant. Hospital acceptance and clinical decisions remain with the treating hospital and its licensed clinicians.
You can review the bladder removal surgery reference for background on the procedure itself, and share your records through the enquiry route when you are ready. Do not delay urgent local assessment while an overseas enquiry is in progress.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.